- In the past quarter ended March 31, 2026, Avient Corporation reported sales of US$847.4 million, net income of US$55.7 million, and GAAP earnings per share of US$0.61, with adjusted EPS of US$0.83 modestly ahead of expectations and improved margins from productivity and cost control efforts.
- An interesting aspect for investors is that Avient maintained its full-year 2026 adjusted EPS guidance and signaled further earnings growth, while simultaneously announcing a CFO transition as Joe Di Salvo steps in to replace Jamie Beggs during this period of margin expansion.
- Next, we will examine how Avient’s better-than-expected adjusted EPS and sustained guidance affect the existing investment narrative for the company.
AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
Avient Investment Narrative Recap
To own Avient, you generally need to believe its shift toward higher value specialty materials and ongoing productivity gains can steadily lift earnings, even if broader polymer demand stays uneven. In that context, the first quarter beat on adjusted EPS and margin expansion support the near term earnings catalyst, while the biggest current risk still looks like demand softness or volatility in larger consumer and packaging markets. The CFO transition, as announced, does not appear to materially change that risk reward balance right now.
The most relevant recent announcement here is Avient’s decision to maintain its full year 2026 adjusted EPS guidance of US$2.93 to US$3.17 despite cost inflation and patchy demand. Holding the outlook after a modest EPS beat suggests management sees its productivity and cost control efforts as durable supports for margins, which ties directly into the core catalyst of efficiency driven earnings improvement. At the same time, it leaves the door open for guidance revisions if end market weakness or supply constraints intensify.
Yet even with expanding margins and steady guidance, investors should be aware that...
Read the full narrative on Avient (it's free!)
Avient's narrative projects $3.6 billion revenue and $263.5 million earnings by 2029. This requires 3.5% yearly revenue growth and about a $181.6 million earnings increase from $81.9 million today.
Uncover how Avient's forecasts yield a $48.57 fair value, a 35% upside to its current price.
Exploring Other Perspectives
Some of the lowest analysts were assuming only about 2 percent annual revenue growth and earnings near US$282.4 million by 2029, which is a much more cautious view than the recent margin progress might imply, so it is worth comparing that pessimism with the latest results and thinking about which scenario you find more realistic.
Explore 2 other fair value estimates on Avient - why the stock might be worth as much as 66% more than the current price!
Decide For Yourself
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Avient research is our analysis highlighting 5 key rewards and 2 important warning signs that could impact your investment decision.
- Our free Avient research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Avient's overall financial health at a glance.
Contemplating Other Strategies?
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
- Find 48 companies with promising cash flow potential yet trading below their fair value.
- Uncover the next big thing with 26 elite penny stocks that balance risk and reward.
- Outshine the giants: these 15 early-stage AI stocks could fund your retirement.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com